Harbor Capital Advisors, Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Harbor Capital Advisors, Inc.
- $1.31 Billion
- Q2 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 65,667 shares of ARCT stock, worth $1.63 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
65,667
Previous 15,958
311.5%
Holding current value
$1.63 Million
Previous $539,000
196.66%
% of portfolio
0.12%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding ARCT
# of Institutions
187Shares Held
25.9MCall Options Held
320KPut Options Held
153K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$116 Million0.28% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$65.6 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.96MShares$48.7 Million0.44% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.56MShares$38.7 Million0.03% of portfolio
-
Nikko Asset Management Americas, Inc.1.56MShares$38.7 Million0.44% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $658M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...